The Swiss-US health technology company Sophia Genetics SA has raised $110 million in a Series F financing round to expand its artificial intelligence service which analyses medical data for use by healthcare professionals. The proceeds will enable the company to develop the platform and expand its operations in the US and Asia.
The Series F round was led by aMoon, a venture fund based in Israel, and Hitachi Ventures, the venture arm of Hitachi Group. Existing investors, including Swisscom Ventures and Endeavour Vision Ltd, also participated.